We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nanoco | AQSE:NANO.GB | Aquis Stock Exchange | Ordinary Share | GB00B01JLR99 | Ordinary Shares 10p |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.3714 | 1.90% | 19.8714 | 18.50 | 20.50 | 19.8714 | 19.50 | 19.50 | 9,984 | 08:00:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMNANO
RNS Number : 9461L
Nanoco Group PLC
07 October 2016
For immediate release 7 October 2016
NANOCO GROUP PLC
("Nanoco" or the "Company" or "Group")
Update re Unaudited Revenues
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces the following update on the timing of revenue recognition of licence agreements signed in July 2016.
The upfront licence fees associated with the agreements are to be recognised over the period of Nanoco's contractual support. It is expected that GBP0.5 million will be released to revenue in the year ending 31 July 2017 and GBP0.7 million will be released over the following six years ending 31 July 2023.
Grant income will be presented as "Other income" in the current year.
The Group's accounts for the year ended 31 July 2016, which remain unaudited, are expected to include revenue of GBP0.4 million, other income of GBP0.3 million and GBP1.2 million in deferred revenue on the Group's balance sheet as at 31 July 2016, giving a total of GBP1.9 million.
The Company's cash position is unaffected by these changes in accounting treatment.
For further information, please contact:
Nanoco Tel: +44 (0) 161 603 7900 Michael Edelman, Chief Executive Officer David Blain, Chief Financial Officer Caroline Watson, Investor Tel: + 44 (0) 7799 Relations Manager 897357 cwatson@nanocotechnologies.com Peel Hunt Tel: +44 (0) 20 7418 8900 Adrian Trimmings George Sellar Buchanan Tel: +44 (0) 20 7466 5000 Mark Court / Sophie Cowles / Stephanie Watson
Notes for editors:
About Nanoco Group plc
Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company, Merck KGaA and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Greater China. Its technology is protected worldwide by a large and growing patent estate.
Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLFFVLIDLRIIR
(END) Dow Jones Newswires
October 07, 2016 02:00 ET (06:00 GMT)
1 Year Nanoco Chart |
1 Month Nanoco Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions